Introduction. Registries are necessary particularly for rare diseases. The REGIS registry was
Introduction
Low-prevalence diseases can pose multiple d i f f i c u l t i e s i n t e r m s o f d i a g n o s i s , m a n a g e m e n t a n d a d v a n c e i n t h e u n d e r s t a n d i n g o f t h e p a t h o g e n i c mechanisms and clinical phenotypes, because of the limited experience of clinicians who rarely encounter such cases.
Long term registries that have a prospective design can overcome these difficulties, as a better understanding of the manifestations of the heterogeneous group of rare diseases can be practical for the creation of a database useful in epidemiology research, and also for a better therapy for the patients that suffer from such diseases . (1) The role of registries is to try and define future standards of care, and also to try and find the best therapeutic and monitoring m e t h o d s f o r t h e s e p a t i e n t s . T h e s e desiderata are based on the current lack of specific treatment agents and easily accessible biomarkers for monitoring diseases, and so rare diseases registries represent the main point of scientific research in the field of rare diseases . (1) Diffuse interstitial lung diseases are considered low prevalence diseases, with estimated incidence and prevalence that vary depending on the region on the globe and the methods used. An increase in epidemiological data is estimated in time, on the one hand due to the improvement of study methods and on the other hand due to the increasing level of interest in these diseases in the medical world and the improvement of the diagnostic process . ' (2) What makes the estimation process problematic is the difficulty of diagnosing diseases because of their low prevalence and confusing them with other more prevalent d i s e a s e s , b u t a l s o b e c a u s e o f t h e unevenness of the terminology -arguments that support the necessity of developing a rare disease registry.
The efforts in developing diffuse interstitial lung disease registries faced a shortcoming in the inclusion process, namely the fact that, in many cases, not all cases from the geographic regions they were conceived for could be entered. For example, the registry in the Bernaillo region in Mexico, in 1988, reported a 81/100000 male prevalence, respectively 67/100000 female prevalence . We can notice a significative variability between registries, especially when referring to the geographic regions they serve. A good example is represented by the Japanese registry in Hokkaido, that estimates a 4.1/100000 prevalence , compared to the (4) Czech registry that estimates a 7-12/100000 prevalence and, furthermore, the Finnish (5) registry estimates a prevalence of 16-18/100000 . (6) Another argument that outlines the geographic variability of diffuse interstitial lung disease prevalence is represented by the retrospective studies, that estimate a 7.6/100000 prevalence for Spain and for (7) Greece a prevalence of 17.3/100000 . (8) Sarcoidosis is a systemic disease of unknown cause that frequently affects the lungs and thoracic lymph nodes and is characterised by non-caseous granulomas and lymphocytic infiltrates . It is a rare disease, with a high (9) incidence and prevalence variability, for example a Korean study shows an incidence of 1.3 -3.4 per 100000 inhabitants and a prevalence of 3.4 per 100000 inhabitants , (10) 
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Original papers compared with the populations of northern European countries, where the annual incidence is estimated at 5 -40 cases per 100000 inhabitants . (11) In Romania it is difficult to quantify the prevalence of sarcoidosis, because of the difficulty in diagnosing it, the lack of clinical s u s p i c i o n a n d t h e h e t e ro g e n e i t y o f extrapulmonary localisation . 
Material and Method
The REGIS registry is an online registry dedicated to diffuse interstitial lung diseases 
